View in EDS HTML Full Text PDF Full Text

Phase II trial of gemcitabine and nab-paclitaxel in patients with recurrent Ewing sarcoma: A report from the National Pediatric Cancer Foundation.

Saved in:
Bibliographic Details
Title: Phase II trial of gemcitabine and nab-paclitaxel in patients with recurrent Ewing sarcoma: A report from the National Pediatric Cancer Foundation.
Authors: Oesterheld JE; Department of Pediatric Hematology, Oncology, Bone Marrow Transplantation, and Palliative Care, Levine Children's Hospital at Atrium Health, Charlotte, North Carolina., Reed DR; Department of Interdisciplinary Cancer Management, Moffitt Cancer Center Adolescent and Young Adult Program, Tampa, Florida., Setty BA; Division of Pediatric Hematology, Oncology and Bone Marrow Transplantation, Nationwide Children's Hospital, Columbus, Ohio., Isakoff MS; Center for Cancer and Blood Disorders, Connecticut Children's Medical Center, Hartford, Connecticut., Thompson P; Division of Pediatric Hematology-Oncology, University of North Carolina Health Care, Chapel Hill, North Carolina., Yin H; Department of Pathology, Children's Healthcare of Atlanta, Atlanta, Georgia., Hayashi M; Department of Pediatrics Hematology-Oncology and Bone Marrow Transplant, Children's Hospital Colorado, Aurora, Colorado., Loeb DM; Department of Pediatrics and Department of Developmental and Molecular Biology, Albert Einstein College of Medicine, New York City, New York., Smith T; National Pediatric Cancer Foundation, Tampa, Florida., Makanji R; Department of Diagnostic Imaging and Interventional Radiology, Moffitt Cancer Center, Tampa, Florida., Fridley BL; Department of Biostatistics and Bioinformatics, Moffitt Cancer Center, Tampa, Florida., Wagner LM; Division of Pediatric Hematology-Oncology, Duke Children's Hospital and Health Center, Durham, North Carolina.
Source: Pediatric blood & cancer [Pediatr Blood Cancer] 2020 Jul; Vol. 67 (7), pp. e28370. Date of Electronic Publication: 2020 May 09.
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: John Wiley Country of Publication: United States NLM ID: 101186624 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1545-5017 (Electronic) Linking ISSN: 15455009 NLM ISO Abbreviation: Pediatr Blood Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 32386107
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Phase II trial of gemcitabine and nab-paclitaxel in patients with recurrent Ewing sarcoma: A report from the National Pediatric Cancer Foundation.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Oesterheld+JE%22">Oesterheld JE</searchLink>; Department of Pediatric Hematology, Oncology, Bone Marrow Transplantation, and Palliative Care, Levine Children's Hospital at Atrium Health, Charlotte, North Carolina.<br /><searchLink fieldCode="AU" term="%22Reed+DR%22">Reed DR</searchLink>; Department of Interdisciplinary Cancer Management, Moffitt Cancer Center Adolescent and Young Adult Program, Tampa, Florida.<br /><searchLink fieldCode="AU" term="%22Setty+BA%22">Setty BA</searchLink>; Division of Pediatric Hematology, Oncology and Bone Marrow Transplantation, Nationwide Children's Hospital, Columbus, Ohio.<br /><searchLink fieldCode="AU" term="%22Isakoff+MS%22">Isakoff MS</searchLink>; Center for Cancer and Blood Disorders, Connecticut Children's Medical Center, Hartford, Connecticut.<br /><searchLink fieldCode="AU" term="%22Thompson+P%22">Thompson P</searchLink>; Division of Pediatric Hematology-Oncology, University of North Carolina Health Care, Chapel Hill, North Carolina.<br /><searchLink fieldCode="AU" term="%22Yin+H%22">Yin H</searchLink>; Department of Pathology, Children's Healthcare of Atlanta, Atlanta, Georgia.<br /><searchLink fieldCode="AU" term="%22Hayashi+M%22">Hayashi M</searchLink>; Department of Pediatrics Hematology-Oncology and Bone Marrow Transplant, Children's Hospital Colorado, Aurora, Colorado.<br /><searchLink fieldCode="AU" term="%22Loeb+DM%22">Loeb DM</searchLink>; Department of Pediatrics and Department of Developmental and Molecular Biology, Albert Einstein College of Medicine, New York City, New York.<br /><searchLink fieldCode="AU" term="%22Smith+T%22">Smith T</searchLink>; National Pediatric Cancer Foundation, Tampa, Florida.<br /><searchLink fieldCode="AU" term="%22Makanji+R%22">Makanji R</searchLink>; Department of Diagnostic Imaging and Interventional Radiology, Moffitt Cancer Center, Tampa, Florida.<br /><searchLink fieldCode="AU" term="%22Fridley+BL%22">Fridley BL</searchLink>; Department of Biostatistics and Bioinformatics, Moffitt Cancer Center, Tampa, Florida.<br /><searchLink fieldCode="AU" term="%22Wagner+LM%22">Wagner LM</searchLink>; Division of Pediatric Hematology-Oncology, Duke Children's Hospital and Health Center, Durham, North Carolina.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101186624%22">Pediatric blood & cancer</searchLink> [Pediatr Blood Cancer] 2020 Jul; Vol. 67 (7), pp. e28370. <i>Date of Electronic Publication: </i>2020 May 09.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22John+Wiley%22">John Wiley </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101186624 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1545-5017 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215455009%22">15455009 </searchLink><i>NLM ISO Abbreviation: </i>Pediatr Blood Cancer <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=32386107
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1002/pbc.28370
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: e28370
    Titles:
      – TitleFull: Phase II trial of gemcitabine and nab-paclitaxel in patients with recurrent Ewing sarcoma: A report from the National Pediatric Cancer Foundation.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Oesterheld JE
      – PersonEntity:
          Name:
            NameFull: Reed DR
      – PersonEntity:
          Name:
            NameFull: Setty BA
      – PersonEntity:
          Name:
            NameFull: Isakoff MS
      – PersonEntity:
          Name:
            NameFull: Thompson P
      – PersonEntity:
          Name:
            NameFull: Yin H
      – PersonEntity:
          Name:
            NameFull: Hayashi M
      – PersonEntity:
          Name:
            NameFull: Loeb DM
      – PersonEntity:
          Name:
            NameFull: Smith T
      – PersonEntity:
          Name:
            NameFull: Makanji R
      – PersonEntity:
          Name:
            NameFull: Fridley BL
      – PersonEntity:
          Name:
            NameFull: Wagner LM
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 07
              Text: 2020 Jul
              Type: published
              Y: 2020
          Identifiers:
            – Type: issn-electronic
              Value: 1545-5017
          Numbering:
            – Type: volume
              Value: 67
            – Type: issue
              Value: 7
          Titles:
            – TitleFull: Pediatric blood & cancer
              Type: main
ResultId 1